National Health Investors Analyst Price Targets

Wall Street analyst price targets and consensus rating for National Health Investors (NHI).

Price Target Range — 13 Quarters

Analyst Consensus — 10 Analysts

6Buy

4Hold

Consensus RatingOverweight# Analysts10Avg. Consensus PT$75Upside to Avg. PT+6.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 2, 2026	Truist Securities	Michael Lewis	PT Cut	Buy	$81→$80
Sep 1, 2026	Wells Fargo	John Kilichowski	PT Cut	Equal-Weight	$79→$78
Jun 25, 2026	Deutsche Bank	Omotayo Okusanya	PT Cut	Hold	$85→$80
Jun 15, 2026	BMO Capital	Juan Sanabria	PT Cut	Outperform	$90→$80
Jun 12, 2026	Truist Securities	Michael Lewis	PT Cut	Buy	$89→$81
Jun 1, 2026	Wells Fargo	John Kilichowski	PT Cut	Equal-Weight	$84→$79
Apr 22, 2026	Wells Fargo	John Kilichowski	PT Cut	Equal-Weight	$86→$84
Apr 22, 2026	Cantor Fitzgerald	Richard Anderson	Maintained	Overweight	$94
Apr 22, 2026	Truist Securities	Michael Lewis	PT Cut	Buy	$92→$89
Mar 27, 2026	Wells Fargo	John Kilichowski	PT Raise	Equal-Weight	$85→$86
Mar 12, 2026	Truist Securities	Michael Lewis	PT Raise	Buy	$85→$92
Dec 16, 2025	Truist Securities	Michael Lewis	PT Raise	Buy	$81→$83
Dec 4, 2025	Keybanc	Todd M. Thomas	PT Raise	Overweight	$80→$88
Nov 25, 2025	Wells Fargo	John Kilichowski	PT Raise	Equal-Weight	$80→$85
Oct 1, 2025	Cantor Fitzgerald	Richard Anderson	Initiate	Overweight	$90
Aug 27, 2025	Wells Fargo	John Kilichowski	PT Raise	Equal-Weight	$76→$80
Aug 15, 2025	Truist Securities	Michael Lewis	PT Raise	Buy	$77→$81
Jul 10, 2025	Keybanc	Craig Mailman	Upgrade	Sector Weight→Overweight	$80
Jun 9, 2025	Truist Securities	Michael Lewis	PT Raise	Hold	$76→$77
Mar 19, 2025	Truist Securities	Michael Lewis	PT Raise	Hold	$70→$76

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $80

Truist Securities analyst Michael Lewis maintains National Health Investors (NYSE:NHI) with a Buy and lowers the price target from $81 to $80.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $78

Wells Fargo analyst John Kilichowski maintains National Health Investors (NYSE:NHI) with a Equal-Weight and lowers the price target from $79 to $78.

Benzinga Newsdesk

PRO
Deutsche Bank Maintains Hold on National Health Investors, Lowers Price Target to $80

Deutsche Bank analyst Omotayo Okusanya maintains National Health Investors (NYSE:NHI) with a Hold and lowers the price target from $85 to $80.

Benzinga Newsdesk

PRO
BMO Capital Maintains Outperform on National Health Investors, Lowers Price Target to $80

BMO Capital analyst Juan Sanabria maintains National Health Investors (NYSE:NHI) with a Outperform and lowers the price target from $90 to $80.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $81

Truist Securities analyst Michael Lewis maintains National Health Investors (NYSE:NHI) with a Buy and lowers the price target from $89 to $81.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $79

Wells Fargo analyst John Kilichowski maintains National Health Investors (NYSE:NHI) with a Equal-Weight and lowers the price target from $84 to $79.

Benzinga Newsdesk

National Health Investors Inc

National Health Investors Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $80

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $78

PRO
Deutsche Bank Maintains Hold on National Health Investors, Lowers Price Target to $80

PRO
BMO Capital Maintains Outperform on National Health Investors, Lowers Price Target to $80

PRO
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $81

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $79

People Also Watch

People Also Watch

National Health Investors Inc

National Health Investors Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROTruist Securities Maintains Buy on National Health Investors, Lowers Price Target to $80

PROWells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $78

PRODeutsche Bank Maintains Hold on National Health Investors, Lowers Price Target to $80

PROBMO Capital Maintains Outperform on National Health Investors, Lowers Price Target to $80

PROTruist Securities Maintains Buy on National Health Investors, Lowers Price Target to $81

PROWells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $79

People Also Watch

People Also Watch

PRO
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $80

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $78

PRO
Deutsche Bank Maintains Hold on National Health Investors, Lowers Price Target to $80

PRO
BMO Capital Maintains Outperform on National Health Investors, Lowers Price Target to $80

PRO
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $81

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $79